CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Can the Vanishing Stent Reappear? Fix the Technique, or Fix the Device? Disrupting Fellow Education Through Group Texting: WhatsApp in Fellow Education? Coronary Angiography after Cardiac Arrest — The Right Timing or the Right Patients? Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up Coronary Artery Calcium Is Associated with Left Ventricular Diastolic Function Independent of Myocardial Ischemia Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial Limitations of Repeat Revascularization as an Outcome Measure Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers
|<<... 65 66 67 68 69 70 71 ...>>|

Review Article2009 May 30;373(9678):1849-60.

JOURNAL：Lancet. Article Link

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Antithrombotic Trialists’ (ATT) Collaboration. Keywords: aspirin; cardiovascular events; primary prevention; diabetes mellitus

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top